Todd Harris, Head of Corporate Development at Sienna Biopharmaceuticals, Inc. (SNNA), sold 7,558 shares at $20.02 ($151K) on 2018-04-10, disclosed to the SEC on 2018-04-12.
Open-market sale of $151k SNNA by Head of Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.02 | 3,779 | $76K | 50.0% |
| 2 | $20.02 | 3,779 | $76K | 50.0% |
| Total | $20.02 avg | 7,558 | $151K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |